Insider Transactions in Q4 2023 at Ani Pharmaceuticals Inc (ANIP)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
25,000
-2.61%
|
$1,300,000
$52.65 P/Share
|
|
Dec 18
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
13,026
-1.34%
|
$677,352
$52.44 P/Share
|
|
Dec 15
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
11,974
-1.22%
|
$622,648
$52.44 P/Share
|
|
Dec 11
2023
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
250
-0.67%
|
$12,250
$49.21 P/Share
|
|
Nov 17
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
13,000
-1.31%
|
$663,000
$51.0 P/Share
|
|
Nov 16
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
6,448
-0.64%
|
$328,848
$51.66 P/Share
|
|
Nov 15
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
7,647
-0.76%
|
$405,291
$53.64 P/Share
|
|
Nov 15
2023
|
Krista Davis SVP, CHIEF HR OFFICER |
SELL
Open market or private sale
|
Direct |
2,622
-7.45%
|
$138,966
$53.81 P/Share
|
|
Nov 14
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
22,095
-2.14%
|
$1,171,035
$53.17 P/Share
|
|
Nov 13
2023
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
250
-0.66%
|
$13,000
$52.03 P/Share
|
|
Nov 10
2023
|
Christopher Mutz HEAD OF RARE DISEASE |
SELL
Open market or private sale
|
Direct |
3,000
-4.5%
|
$156,000
$52.47 P/Share
|
|
Oct 19
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
10,000
-0.96%
|
$570,000
$57.06 P/Share
|
|
Oct 18
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
6,242
-0.6%
|
$355,794
$57.78 P/Share
|
|
Oct 17
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
8,758
-0.83%
|
$507,964
$58.53 P/Share
|
|
Oct 16
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
13,063
-1.22%
|
$757,654
$58.31 P/Share
|
|
Oct 13
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
11,937
-1.1%
|
$680,409
$57.58 P/Share
|
|
Oct 02
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-6.39%
|
$1,120,000
$56.48 P/Share
|